The result marks a potential advance for dual-targeting antibody drugs like Tecvayli, which are currently relegated to ...
Such a warning appears on the medicine’s label and is the most serious issued by the FDA. The FDA said it received reports ...
The U.S. Food and Drug Administration approved on Friday labeling changes for the blood cancer therapy of Johnson & Johnson ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback